Artikel ; Online: Solubility Enhancement of Antidiabetic Drugs Using a Co-Crystallization Approach.
2021 Band 10, Heft 12, Seite(n) 1260–1268
Abstract: The co-crystallization approach has been used to enhance specific desirable properties of active pharmaceutical ingredients (APIs) such as solubility, dissolution rate, and stability. Solubility is a fundamental property that affects the bioavailability ... ...
Abstract | The co-crystallization approach has been used to enhance specific desirable properties of active pharmaceutical ingredients (APIs) such as solubility, dissolution rate, and stability. Solubility is a fundamental property that affects the bioavailability and dosage of the API. The co-crystal approach is one of the emerging methods with the potential for improving the solubility of these drugs. This paper reviews the latest progress on improving the solubility of some antidiabetic drug molecules using the co-crystal approach. |
---|---|
Mesh-Begriff(e) | Biological Availability ; Crystallization ; Hypoglycemic Agents ; Solubility |
Chemische Substanzen | Hypoglycemic Agents |
Sprache | Englisch |
Erscheinungsdatum | 2021-12-18 |
Erscheinungsland | Germany |
Dokumenttyp | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 2655605-4 |
ISSN | 2191-1363 ; 2191-1363 |
ISSN (online) | 2191-1363 |
ISSN | 2191-1363 |
DOI | 10.1002/open.202100246 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.